- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02125422
Neurophysiological Study of tDCS Effects in Healthy Volunteers (tDCSHV)
Study Overview
Detailed Description
Anodal transcranial direct currenti stimulation over visual cortex is able to decrease the thermo-nociceptive sensibility and thermonociceptive potentials, whilst cathodal transcranial direct current stimulation has the opposite effect, it decreases VEP amplitude and habituation. This neuromodulation technique is probably a tool in the prevention in episodic and chronic migraine.
The aim of the study is to study short and long term effect of tDCS over pain treshold, contact heat evoked potentials, blink reflex and visual evoked potentials in healthy volunteers.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Liége, Belgium, 4000
- Roberta Baschi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy volunteers
Exclusion Criteria:
- age below 18 or above 65 years
- personal history of recurrent headache or other neurological diseases especially seizures,
- familial history of recurrent headache
- child migraine equivalents (motion sickness, cyclic vomiting or recurrent abdominal pain, somnambulism etc.. . .)
- chronic pain syndromes
- analgesics intake at the time of recording
- contra-indications to tDCS neurostimulation (metal prosthetics in the head or internal stimulation like a pacemaker).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cefaly tDCS
Cathodal Cefaly tDCS is delivered over the visual cortex at 2 mA of intensity, for 20 minutes, for 5 consecutive days in 9 HV. The anode is placed over the left DLPFC. 2 mA anodal tDCS is delivered over the visual cortex, for 20 minutes, for 5 consecutive days in 9 HV |
Cefaly tDCS (transcranial direct current stimulation) is able to modify cortical excitability, in particular anodal tDCS increases it.
The side effects of tDCS are minor, especially sensations of itching and scalp paresthesias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurophysiological mesures changes
Time Frame: up to 1 month
|
Modifications in neurophysiological test after direct current stimulation
|
up to 1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VEP changes
Time Frame: up to 1 month
|
Evaluation of changes in latency, amplitude, slope and habituation
|
up to 1 month
|
|
Blink changes
Time Frame: up to 1 month
|
Evaluation of changes in latency, amplitude, slope and habituation
|
up to 1 month
|
|
CHEPS changes
Time Frame: up to 1 month
|
Evaluation of changes in latency, amplitude, slope and habituation
|
up to 1 month
|
|
Quantitave Sensory Testing
Time Frame: up to 1 month
|
Evaluation of changes in thresholds
|
up to 1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Delphine Magis, MD, University of Liege
- Principal Investigator: Jean Schoenen, MD, University of Liege
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CB-1200
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Cefaly tDCS
-
University of LiegeWithdrawn
-
University of LiegeCompletedChronic Cluster HeadacheBelgium
-
University of LiegeCompletedCathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial (CATCHROMIG)Chronic MigraineBelgium
-
VA Office of Research and DevelopmentCompleted
-
Saint Vincent's Hospital, KoreaCompletedSleep Initiation and Maintenance DisordersKorea, Republic of
-
Cefaly TechnologyCompleted
-
Cefaly TechnologyCompleted
-
Cefaly TechnologyCompleted
-
Cefaly TechnologyCompleted